26 April 2016 - CADTH has received notice of a pending submission from Ferring Pharmaceuticals for budesonide for use by patients with ulcerative colitis.

For more details, go to: https://www.cadth.ca/budesonide?utm_source=%2ALIVE%2A+CADTH%2FACMTS+Confirmed+Subscribers&utm_campaign=27254a5b82-PI-confidential-4-26-2016&utm_medium=email&utm_term=0_2e3705996c-27254a5b82-262951505